CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 156 enrolled
Drug / intervention
Whole blood for genotypinggenetic
Likely dose
Whole blood for genotyping 8.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01557751
NCT01557751N/ACompleted

Preliminary Studies for Whole Genome Association Study (WGAS) in Acute Perioperative Pain

University of Pittsburgh·interventional·Posted Mar 19, 2012·Updated May 12, 2023

In Brief

A clinical study evaluating Whole blood for genotyping for Osteoarthritis and Postoperative Pain. Completed, enrolled 156 participants across 1 site.

Detailed Summary

In preparation for future large-scale genome wide association studies, reliable methods must be developed for measuring perceived pain and for estimating the effects of potentially confounding factors such as appropriate covariates. The major objectives of our pilot investigation are to develop optimal methods to characterize the primary endpoint of the study-knee pain, and to gather preliminary data on genetic markers in the human genome that are associated with a certain pain phenotype. The specific issues for this study will be to carry out a preliminary gene association analysis of acute perioperative pain in individuals undergoing total knee replacement and to define a pain phenotype that is composed of multidimensional domains such as opioid consumption, inflammatory markers, anxiety level, degree of catastrophizing, etc. This pain phenotype has to be sensitive enough to pick up changes in pain experience that can be attributed to single nucleotide polymorphisms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 19, 2012
Enrollment StartFeb 1, 2010
Primary CompletionApr 8, 2011
Study CompletionApr 8, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.3 years ago

Interventions

Whole blood for genotypinggenetic

This study requires genotyping by extracting DNA from blood sample. A blood sample will be drawn once during visit 2 (day of surgery) or any other time prior to that after the signing of informed consent. Four vacutainers of which hold 8.5 mL will be drawn during this time totaling approximately 34 mL of blood which completes the genomic sampling portion of the study.